MedPath

The Therapeutic Effect of Dysthyroid Optic Neuropathy

Not Applicable
Conditions
Thyroid Eye Disease
Registration Number
NCT04096612
Lead Sponsor
Sun Yat-sen University
Brief Summary

Thyroid associated ophthalmopathy (TAO) is a common autoimmune disorder. The pathogenesis of TAO is unclear, and studies found that T cell, B cell and monocytes, macrophages and mast cells are located in the orbital tissue of TAO. Dysthyroid optic neuropathy (DON) is the most serious complication of TAO, which can cause blurred vision, color vision and vision function damage, and affects the quality of life. Investigation of the therapeutic effect of orbital decompression may provide some clues to make the policy at treatment of DON. We explore the therapeutic effect of orbital decompression in patients with DON in both eyes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Ability to perform visual fields and VEP examination Without any serious systemic diseases Without any surgery on eyes in six months
Exclusion Criteria
  • With any serious systemic diseases With any surgery on eyes in six months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
proptosis6 months

proptosis in mm

upper eyelid retraction6 months

upper eyelid retraction in mm

CAS6 months

clinical activity score

BCVA6 months

best corrected visual acuity in logMAR

IOP6 months

intraocular pressure in mmHg

Secondary Outcome Measures
NameTimeMethod
MD6 months

mean deviation of visual field in dB

PSD6 months

pattern standard deviation of visual field in dB

Trial Locations

Locations (1)

Zhongshan Opthalmic Center

🇨🇳

Guangdong, Guangdong, China

Zhongshan Opthalmic Center
🇨🇳Guangdong, Guangdong, China
Huasheng Yang, M.D.
Contact
+8620-87331539
yanghs64@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.